ALKALI vs TATVA: Stock Comparison
TATVA CHIN PHARM CHEM is the larger company by market capitalisation. ALKALI METALS shows a higher dividend yield and a higher ROCE, while TATVA CHIN PHARM CHEM shows a higher ROE, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
ALKALI leads 2; TATVA leads 9 of 11
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | ALKALI | TATVA |
|---|---|---|
| Sector | Chemicals | Chemicals |
| Industry | Specialty Chemicals | Specialty Chemicals |
Price
| Metric | ALKALI | TATVA |
|---|---|---|
| Live Price | ₹77.25 | ₹1,608.7 |
| Day Change | -2.45% | -3.04% |
| Volume | 19,801 | 47,765 |
| 52-Week High | ₹107.38 | ₹1,838.1 |
| 52-Week Low | ₹46.8 | ₹981.5 |
| Distance from 52W High | -28.06% | -12.48% |
Valuation
| Metric | ALKALI | TATVA |
|---|---|---|
| Market Cap | ₹78 Cr | ₹3,756 Cr |
| P/E Ratio | — | 73.08x |
| P/B Ratio | — | 4.8x |
| EPS | ₹-0.63 | ₹4.47 |
| Book Value | ₹43.89 | ₹334.2 |
| Dividend Yield | 1.31% | 0.12% |
Growth
| Metric | ALKALI | TATVA |
|---|---|---|
| Revenue Growth (TTM YoY) | 2.98% | 24.4% |
| EPS Growth (TTM YoY) | 0% | 907.5% |
| Qtr Sales Growth | -38.87% | -12.18% |
| Qtr Profit Growth | -116.04% | -34.63% |
Profitability & Leverage
| Metric | ALKALI | TATVA |
|---|---|---|
| ROE | 1.24% | 5.38% |
| ROCE | 6.4% | 4.93% |
| Net Margin | 0.6% | 8.31% |
| Operating Margin | 5.68% | 11.83% |
| Debt to Equity | 0.4x | 0.15x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | ALKALI | TATVA |
|---|---|---|
| Promoter Holding | 68.51% | 72.02% |
| FII Holding | 0% | 3.93%▲ 0.11 pp |
| DII Holding | 0% | 3.11%▲ 0.12 pp |
| Public Holding | 30.41% | 20.94%▼ 0.23 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ALKALI METALS and TATVA CHIN PHARM CHEM.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.